The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Respiratory Journal

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.01.00064101PMID 11510804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonspecific airway hyperresponsiveness in HIV disease.

  1998cited by this paper
• Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma.

  1998cited by this paper
• A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.

  1997cited by this paper
• Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis.

  1997cited by this paper
• IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease.

  1997cited by this paper
• Differential functional effects of a humanized anti‐CD4 antibody on resting and activated human T cells

  1997cited by this paper
• Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary Complications of HIV Infection Study Group.

  1997cited by this paper
• Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens.

  1996cited by this paper
• Asthma and related atopic disorders in outpatients attending an urban HIV clinic.

  1995cited by this paper
• Functional analysis of the effects of a fully humanized anti-CD4 antibody on resting and activated human T cells.

  1995cited by this paper
• The effect of anti‐CD4 on helper function of CD4, 45RA+ versus CD4, 45RO+ T cells

  1994cited by this paper
• Peripheral T lymphocyte depletion by apoptosis after CD4 ligation in vivo: selective loss of CD44− and ‘activating’ memory T cells

  1994cited by this paper
• Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells.

  1994cited by this paper
• Chimaeric anti‐CD4 monoclonal antibody cross‐linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes

  1993cited by this paper
• Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness.

  1993cited by this paper
• Down-regulation of cell surface CD4 molecule expression induced by anti-CD4 antibodies in human T lymphocytes.

  1992cited by this paper
• “Primatization” of Recombinant Antibodies for Immunotherapy of Human Diseases: A Macaque/Human Chimeric Antibody Against Human CD4

  1992cited by this paper
• EVIDENCE THAT LONG‐TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLS

  1992cited by this paper
• Elevation of IgE in HIV-infected subjects: a marker of poor prognosis.

  1992cited by this paper
• Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity.

  1991cited by this paper
• CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration

  1991cited by this paper
• T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.

  1991cited by this paper
• CD4 T lymphocyte activation in acute severe asthma.

  1991cited by this paper
• CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

  1990cited by this paper
• Eosinophilic inflammation in asthma.

  1990cited by this paper
• Serum IgE and human immunodeficiency virus (HIV) infection.

  1990cited by this paper
• Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.

  1990cited by this paper
• Memory T cells

  1989cited by this paper
• Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen.

  1986cited by this paper
• Perturbation of the T4 molecule transmits a negative signal to T cells

  1985cited by this paper

• Anti-IL-5 therapies for asthma.

  2022cites this paper
• Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma.

  2021cites this paper
• Futuras terapias biológicas en el asma

  2018cites this paper
• Tolerogenic Dendritic Cells Reduce Airway Inflammation in a Model of Dust Mite Triggered Allergic Inflammation

  2018cites this paper
• eview uture Biologic Therapies in Asthma

  2018cites this paper
• Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy

  2017cites this paper
• Anti-IL5 therapies for asthma.

  2017cites this paper
• BAZELE PATOGENICE ALE TRATAMENTULUI MEDICAMENTOS ÎN ASTMUL BRON Ş IC LA COPIL

  2016cites this paper
• Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.

  2015cites this paper
• Clinical research on asthma through bronchial biopsy: investigación clínica en asma mediante biopsia bronquial

  2015cites this paper
• CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in COPD CD8 cells

  2015cites this paper
• Role of synergism between RV Infection and Atopy in the Pathophysiology of Intermittent Asthmatic Bronchitis in Adolescent Group in Mansoura

  2015cites this paper
• Anticuerpos monoclonales en el asma. Posibilidad de tratamiento “a la carta”

  2015cites this paper
• Mepolizumab versus placebo for asthma.

  2015cites this paper
• Characterisation of a novel tick-derived dendritic cell modulator, Japanin

  2014cites this paper
• A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

  2014cites this paper
• CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patients.

  2014cites this paper
• Future biologic therapies in asthma.

  2014cites this paper
• Redução da inflamação das vias aéreas e da produção de anticorpos IgE através do uso de células dendríticas tolerogênicas pulsadas com extrato solúvel de Blomia tropicalis

  2014cites this paper
• Future Biologic Therapies in Asthma

  2014cites this paper
• The role of IL-4 receptor alpha in chronic allergic airway disease (AAD)

  2013cites this paper
• Stratified approaches to the treatment of asthma

  2013cites this paper
• Molecular characterization of woodchuck CD4 (wCD4) and production of a depletion monoclonal antibody against wCD4.

  2013cites this paper
• Monoclonal antibodies for asthma and chronic obstructive pulmonary disease

  2013cites this paper
• Airway smooth muscle in the pathophysiology and treatment of asthma.

  2013cites this paper
• Disabling inflammatory pathways with biologics and resulting clinical outcomes in severe asthma

  2013cites this paper
• Boosting regulatory T cell function by CD4 stimulation enters the clinic

  2012cites this paper
• Biologics therapies for severe asthma

  2012cites this paper
• Development of Antibody-Based Therapeutics

  2012cites this paper
• Preclinical Safety Considerations for the Development of Antibody-Based Therapeutics

  2012cites this paper
• Monoclonal antibodies for chronic refractory asthma and pipeline developments.

  2012cites this paper
• Innate and adaptive immune responses in asthma

  2012cites this paper
• Challenges in the Management of Severe Asthma: Role of Current and Future Therapies

  2011cites this paper
• Monoclonal Antibodies for the Treatment of Severe Asthma

  2011cites this paper
• Asthma translational medicine: report card.

  2011cites this paper
• Abordagem farmacoterapêutica na asma

  2011cites this paper
• Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?

  2011cites this paper
• Challeges in the management of severe asthma: role of current and future therapies.

  2011cites this paper
• Update on Biological Therapeutics for Asthma

  2010cites this paper
• BASIC AND CLINICAL TRANSLATIONAL SCIENCE IN ALLERGY ,A STHMA AND IMMUNOLOGY REVIEW SERIES Update on Biological Therapeutics for Asthma

  2010cites this paper
• Biologic therapies for asthma

  2010cites this paper
• Janus kinase-3 dependent inflammatory responses in allergic asthma.

  2010cites this paper
• Monoclonal antibodies and other biologic agents in the treatment of asthma

  2009cites this paper
• In vitro end points for the assessment of cellular immune response-modulating drugs

  2009cites this paper
• T lymphocyte Recruitment to the Lung in Asthma

  2009cites this paper
• The use of monoclonal antibodies and related agents in the treatment of respiratory disease.

  2009cites this paper
• In vitroendpointsforthe assessmentofcellularimmune response-modulatingdrugs

  2009cites this paper
• Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.

  2009cites this paper
• Biologics in asthma: difficulties and drawbacks

  2008cites this paper
• Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.

  2008cites this paper
• [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].

  2008cites this paper
• [Targeted immunologic therapies for severe asthma].

  2008cites this paper
• Thérapeutiques immunologiques ciblées dans l’asthme sévère

  2008cites this paper
• Allergen-Induced Inflammation

  2008cites this paper
• Human recombinant interleukin-12 and circulating CD4 and CD8 T cells in patients with mild allergic asthma

  2008cites this paper
• Investigation of the role of T cells in airway inflammation using novel murine models of disease

  2007cites this paper
• Identification of novel genes associated with allergen-driven T cell activation in human atopics

  2007cites this paper
• Preclinical safety testing of monoclonal antibodies: the significance of species relevance

  2007cites this paper
• CD4‐mediated functional activation of human CD4+CD25+ regulatory T cells

  2007cites this paper
• Asthma treatment: ‘magic bullets which seek their own targets’

  2007cites this paper
• Current perspectives Update on glucocorticoid action and resistance

  2006cites this paper
• Synthesis and Structure−Activity Relationship Studies of CD4 Down-Modulating Cyclotriazadisulfonamide (CADA) Analogues

  2006cites this paper
• Update on glucocorticoid action and resistance.

  2006cites this paper
• Targeting memory Th2 cells for the treatment of allergic asthma.

  2006cites this paper
• A role for natural killer T cells in asthma

  2006cites this paper
• Update in Asthma Treatment

  2006cites this paper
• Immunomodulation

  2006cites this paper
• The future of asthma therapy

  2005cites this paper
• Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease.

  2004cites this paper
• ИССЛЕДОВАНИЕ МЕМБРАННЫХ РЕЦЕПТОРОВ Т-ЛИМФОЦИТОВ В ИНДУЦИРОВАННОЙ МОКРОТЕ БОЛЬНЫХ БРОНХИАЛЬНОЙ АСТМОЙ И ХРОНИЧЕСКИМ ОБСТРУКТИВНЫМ БРОНХИТОМ Владивостокский государственный медицинский университет

  2004cites this paper
• Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?

  2004cites this paper
• Chronic inflammation in asthma

  2003cites this paper
• Exploring New Frontiers in Asthma Management for Optimal and Economic Outcomes

  2003cites this paper
• The CX3C chemokine fractalkine in allergic asthma and rhinitis.

  2003cites this paper
• Emerging Therapeutic Strategies for Asthma Management

  2003cites this paper
• Budesonide/formoterol for the treatment of asthma

  2003cites this paper
• Resolution of late-onset asthma following high-dose chemotherapy

  2003cites this paper
• Anti-Interleukin-5 Monoclonal Antibodies

  2003cites this paper
• Asthma: future directions.

  2002cites this paper
• Glucocorticoid-resistant asthma

  2002cites this paper
• Immunomodulation and asthma: possibilities and potential

  year unknowncites this paper